First Time Loading...

Jiangsu Nhwa Pharmaceutical Co Ltd
SZSE:002262

Watchlist Manager
Jiangsu Nhwa Pharmaceutical Co Ltd Logo
Jiangsu Nhwa Pharmaceutical Co Ltd
SZSE:002262
Watchlist
Price: 25.01 CNY -0.28% Market Closed
Updated: May 1, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Jiangsu Nhwa Pharmaceutical Co Ltd

Wall Street analysts forecast Jiangsu Nhwa Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Jiangsu Nhwa Pharmaceutical Co Ltd is 28.31 CNY with a low forecast of 14.95 CNY and a high forecast of 37.77 CNY.

Lowest Forecast
Wall Street Target
14.95 CNY
40% Downside
Average Forecast
Wall Street Target
28.31 CNY
13% Upside
Highest Forecast
Wall Street Target
37.77 CNY
51% Upside
Lowest
Price Target
14.95 CNY
40% Downside
Average
Price Target
28.31 CNY
13% Upside
Highest
Price Target
37.77 CNY
51% Upside
Jiangsu Nhwa Pharmaceutical Co Ltd Competitors:
Price Targets
MRK
Merck & Co Inc
8% Upside
2348
Dawnrays Pharmaceutical (Holdings) Ltd
133% Upside
S
4565
Sosei Group Corp
54% Upside
GLAXO
GlaxoSmithKline Pharmaceuticals Ltd
2% Downside
MRK
Merck & Co Inc
8% Upside
2348
Dawnrays Pharmaceutical (Holdings) Ltd
133% Upside
S
4565
Sosei Group Corp
54% Upside
GLAXO
GlaxoSmithKline Pharmaceuticals Ltd
2% Downside
D
000640
Dong-A Socio Holdings Co Ltd
32% Upside
Z
002332
Zhejiang Xianju Pharmaceutical Co Ltd
36% Upside
W
300871
Wuhan Hvsen Biotechnology Co Ltd
27% Upside
688513
Chengdu Easton Biopharmaceuticals Co Ltd
4% Upside

Revenue
Forecast

Revenue Estimate
Jiangsu Nhwa Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Jiangsu Nhwa Pharmaceutical Co Ltd's revenue is 8%. The projected CAGR for the next 3 years is 20%.

8%
Past Growth
20%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Jiangsu Nhwa Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Jiangsu Nhwa Pharmaceutical Co Ltd's operating income is 18%. The projected CAGR for the next 3 years is 24%.

18%
Past Growth
24%
Estimated Growth
Estimates Accuracy
-9%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Jiangsu Nhwa Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Jiangsu Nhwa Pharmaceutical Co Ltd's net income is 19%. The projected CAGR for the next 3 years is 22%.

19%
Past Growth
22%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Jiangsu Nhwa Pharmaceutical Co Ltd's stock price target?
Price Target
28.31 CNY

According to Wall Street analysts, the average 1-year price target for Jiangsu Nhwa Pharmaceutical Co Ltd is 28.31 CNY with a low forecast of 14.95 CNY and a high forecast of 37.77 CNY.

What is Jiangsu Nhwa Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
20%

For the last 8 years the compound annual growth rate for Jiangsu Nhwa Pharmaceutical Co Ltd's revenue is 8%. The projected CAGR for the next 3 years is 20%.

What is Jiangsu Nhwa Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
24%

For the last 8 years the compound annual growth rate for Jiangsu Nhwa Pharmaceutical Co Ltd's operating income is 18%. The projected CAGR for the next 3 years is 24%.

What is Jiangsu Nhwa Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
22%

For the last 8 years the compound annual growth rate for Jiangsu Nhwa Pharmaceutical Co Ltd's net income is 19%. The projected CAGR for the next 3 years is 22%.

ALPHA SPREAD
Join more than 133,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.